[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607150":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":34,"collaborators":10,"id":38,"slug":10,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":39,"sex":44,"minAge":45,"maxAge":10,"enrollmentInfo":46,"targetDuration":10,"studyType":49,"phases":10,"briefSummary":50,"conditions":51,"keywords":10,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":63},{"fullName":5,"class":6},"China-Japan Friendship Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"TAK-PAI group",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Wanmu Xie, Doctor","CONTACT","15611734410","xiewanmu@126.com",[18],{"facility":19,"status":20,"city":21,"state":22,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"China-Japan Friendship hospital","RECRUITING","Beijing","Beijing Municipality","100029","China","CN",{"type":27,"coordinates":28},"Point",[29,30],116.39723,39.9075,{"lat":30,"lon":29},[33],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},{"type":35,"investigatorFullName":36,"investigatorTitle":37,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Wanmu Xie","Director, Department of Integrative Pulmonary Medicine","100607150",false,"NCT07184814","Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement","CAPTAIN","Inclusion Criteria:\n\n* Hospitalized between Jan 1, 2016 and Dec 31, 2026\n* Diagnosed with TAK according to the modified Ishikawa criteria and\u002For 1990 American College of Rheumatology criteria and\u002For 2022 ACR\u002FEULAR criteria\n* Diagnosed with pulmonary artery involvement using computed tomography pulmonary angiography or transcatheter pulmonary angiography\n* Patients without aortic or primary branch involvement who nonetheless exhibited both clinical features and computed tomography-confirmed evidence of pulmonary artery involvement (PAI), after exclusion of other diseases causing pulmonary artery stenosis or occlusion\n\nExclusion Criteria:\n\n* Patients with PAI caused by non-TAK diseases such as other types of vasculitis, fibrosing mediastinitis, pulmonary artery sarcoma, pulmonary sarcoidosis or chronic thromboembolic pulmonary hypertension","ALL","18 Years",{"count":47,"type":48},150,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).",[52,53],"Takayasu Arteritis With Pulmonary Artery Involvement","Pulmonary Arterial Hypertension Associated With Connective Tissue Disease","2025-09-19",{"date":56,"type":57},"2025-09-22","ACTUAL",{"date":59,"type":57},"2016-01-01",{"date":61,"type":48},"2026-12-31",{"name":5,"class":6},1]